Joint modeling of progression of HIV resistance mutations measured with uncertainty and failure time data

Biometrics

Volumn 63, Issue 1, 2007, Pages 60-68

  Hu, Chengcheng ^a   De Gruttola, Victor ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cox regression; Failure time data; Markov models; Model checking; Sequencing error; Survival data

Indexed keywords

IMAGE SEGMENTATION; MAXIMUM PRINCIPLE; MODEL CHECKING; SAMPLING; UNCERTAINTY ANALYSIS;

ANTIRETROVIRAL TREATMENT; COX REGRESSION; FAILURE TIME DATA; GENETIC TREATMENT; JOINT MODELS; MARKOV MODELING; MODELS CHECKING; SEQUENCING ERRORS; SURVIVAL DATA; UNCERTAINTY;

HIDDEN MARKOV MODELS;

ASSESSMENT METHOD; DISEASE RESISTANCE; HUMAN IMMUNODEFICIENCY VIRUS; MARKOV CHAIN; MEASUREMENT METHOD; MODEL TEST; MODEL VALIDATION; MODELING; MUTATION; UNCERTAINTY ANALYSIS;

ARTICLE; CONTROLLED STUDY; EXPECTATION; GENE MUTATION; GENE SEQUENCE; GENETIC ALGORITHM; GENOTYPE; HEREDITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFORMATION PROCESSING; MATHEMATICAL MODEL; NONHUMAN; PROPORTIONAL HAZARDS MODEL; SIMULATION; TREATMENT FAILURE; VIRAL GENETICS; VIRUS RESISTANCE;

EID: 34247239303     PISSN: 0006341X     EISSN: 15410420     Source Type: Journal    
DOI: 10.1111/j.1541-0420.2006.00635.x     Document Type: Article

References (18)

1. Albert, A. (1962). Estimating the infinitesimal generator of a continuous time, finite state Markov process. Annals of Mathematical Statistics 33, 727-753.
2. Bacheler, L. T., Anton, E. D., Kudish, P., et al. (2000). Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy. Antimicrobial Agents and Chemotherapy 44, 2475-2484.
3. Breslow, N. E. (1972). Contribution to the discussion of the paper by D. R. Cox. Journal of the Royal Statistical Society, Series B 34, 187-220.
4. Chen, H. Y. and Little, R. J. A. (1999). Proportional hazards regression with missing covariates. Journal of the American Statistical Association 94, 896-908.
5. Cleveland, W. S. (1979). Robust locally weighted regression and smoothing scatterplots. Journal of the American Statistical Association 74, 829-836.
6. Cox, D. R. (1972). Regression models and life tables (with discussion). Journal of the Royal Statistical Society, Series B 34, 187-220.
7. Cox, D. R. (1975). Partial likelihood. Biometrika 62, 269-276.
8. Fleming, T. R. and Harrington, D. P. (1991). Counting Processes and Survival Analysis. New York: John Wiley & Sons.
9. Foulkes, A. S. and De Gruttola, V. (2003). Characterizing the progression of viral mutations over time. Journal of the American Statistical Association 98, 859-867.
10. Kalbfleisch, J. and Lawless, J. (1985). The analysis of panel data under a Markov assumption. Journal of the American Statistical Association 80, 863-871.
11. Kalbfleisch, J. D. and Prentice, R. L. (2002). The Statistical Analysis of Failure Time Data, 2nd edition. Hoboken, New Jersey: Wiley.
12. Loecke, D. (2004). Addition of covariates to a Markov model approach for characterizing the progression of HIV genetic mutations. Ph.D. Thesis, Harvard University, Boston.
13. Louis, T. A. (1982). Finding the observed information matrix when using the EM algorithm. Journal of the Royal Statistical Society, Series B 44, 226-233.
14. Martinussen, T. (1999). Cox regression with incomplete covariate measurements using the EM-algorithm. Scandinavian Journal of Statistics 26, 479-491.
15. Murphy, S. A. (1995). Asymptotic theory for the frailty model. Annals of Statistics 23, 182-198.
16. Murphy, S. A. and van der Vaart, A. W. (2000). On profile likelihood (with discussions). Journal of the American Statistical Association 95, 449-485.
17. Parner, E. (1998). Asymptotic theory for the correlated gamma-frailty model. Annals of Statistics 26, 183-214.
18. Shafer, R. (2004). Stanford University HIV Drug Resistance Database. Available at http://hivdb.stanford.edu/.